TMCnet News

Research and Markets: Emphysema - Pipeline Review, H2 2013 Research Report

[February 14, 2014]

Research and Markets: Emphysema - Pipeline Review, H2 2013 Research Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/29llvr/emphysema) has announced the addition of the "Emphysema - Pipeline Review, H2 2013" report to their offering.

'Emphysema - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Emphysema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Emphysema.

Scope

- A snapshot of the global therapeutic scenario for Emphysema.

- A review of the Emphysema products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- overage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Emphysema pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

Introduction

Emphysema Overview

Therapeutics Development

Emphysema - Pipeline Products Glance

Clinical Stage Products

Early Stage Products

Unknown Stage Products

Icure Pharmaceutical Inc.

Emphysema - Therapeutics Assessment

Drug Profiles

Alpha 1-Proteinase Inhibitor - Drug Profile

HI-164OV - Drug Profile

Lysine Acetylsalicylate - Drug Profile

Alpha-1 Antitrypsin With rHuPH20 - Drug Profile

Drug For Emphysema - Drug Profile

Retinoic Acid Receptor Agonists - Drug Profile

formoterol fumarate Patch - Drug Profile